Breaking News Instant updates and real-time market news.

MMYT

MakeMyTrip

$23.22

0.23 (1.00%)

07:49
11/04/19
11/04
07:49
11/04/19
07:49

MakeMyTrip reports Q2 adjusted EPS (31c), consensus (28c)

Reports Q2 adjusted revenue $181.1M, one estimate $179.98M. Reports gross bookings increased 20.6% year-over-year in 2Q20 to $1.5B. "The MakeMyTrip Group continued to expand its bouquet of travel offerings during the seasonally weak fiscal second quarter. We continued to deliver greater value for users and suppliers, sharply optimizing our marketing and sales promotion spend and gaining share, even as we operate under challenging growth conditions," said Deep Kalra, Group Chairman and Group CEO.

  • 04

    Nov

MMYT MakeMyTrip
$23.22

0.23 (1.00%)

11/27/18
NOMU
11/27/18
UPGRADE
NOMU
Buy
MakeMyTrip upgraded to Buy from Neutral at Nomura Instinet
11/27/18
11/27/18
UPGRADE
Target $31

Buy
MakeMyTrip upgraded to Buy after pullback at Nomura Instinet
As previously reported, Nomura Instinet analyst Ashwin Mehta upgraded MakeMyTrip to Buy from Neutral following the stock having corrected by about 45% from its peak on concerns of possibly weaker air traffic growth and moderation of the company's Hotels & Packages growth. Mehta continues to believe break-even is likely in FY21, which is a year later than management indications, but is enthused by the rationalization of discounting visible in the firm's survey of hotels and signs of lower competitive intensity in H&P, the analyst tells investors. Mehta lowered the price target on MakeMyTrip shares to $31 from $35.
02/04/19
OPCO
02/04/19
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades Yatra to Perform on lack of catalysts
Oppenheimer analyst Jed Kelly downgraded Yatra Online (YTRA) to Perform from Outperform and removed his prior $8 price target. The analyst sees a lack of near-term catalysts for the shares. The stock will likely be range-bound based on decelerating revenue trends, Kelly tells investors in a research note. The analyst forecasts fiscal 2020 marketing leverage of up 370 basis points year-over-year, which he calls "underwhelming" for an emerging market company growing revenue in the mid-teens. Further, this should also limit the narrative that Yatra's corporate segment is a differentiator to MakeMyTrip (MMYT), says Kelly.
04/30/19
BOFA
04/30/19
DOWNGRADE
Target $25
BOFA
Underperform
MakeMyTrip downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Sachin Salgaonkar double downgraded MakeMyTrip to Underperform from Buy and cut its price target to $25 citing weak fundamentals and unfavorable risk/reward. The analyst expects the Jet Airways grounding to negatively impact MakeMyTrip traffic volumes as ticket prices move up. Salgaonkar now expects EBITDA breakeven to be pushed to 7-8 quarters versus his previous estimate of four quarters.

TODAY'S FREE FLY STORIES

LULU

Lululemon

$231.08

1.58 (0.69%)

07:42
12/10/19
12/10
07:42
12/10/19
07:42
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GOLD

Barrick Gold

$16.85

-0.045 (-0.27%)

07:41
12/10/19
12/10
07:41
12/10/19
07:41
Hot Stocks
Barrick Gold to sell 90% interest in Massawa project to Teranga for up to $430M »

Barrick Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$62.68

-1.77 (-2.75%)

07:41
12/10/19
12/10
07:41
12/10/19
07:41
Hot Stocks
Sage Therapeutics announces planned progression of SAGE-718 »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$237.33

-4.62 (-1.91%)

07:40
12/10/19
12/10
07:40
12/10/19
07:40
Recommendations
RH analyst commentary  »

RH price target raised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCC

Wesco

$54.92

-0.32 (-0.58%)

, AXE

Anixter

$88.88

-0.18 (-0.20%)

07:39
12/10/19
12/10
07:39
12/10/19
07:39
Upgrade
Wesco, Anixter rating change  »

Wesco upgraded to Strong…

WCC

Wesco

$54.92

-0.32 (-0.58%)

AXE

Anixter

$88.88

-0.18 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NFLX

Netflix

$302.48

-4.88 (-1.59%)

07:39
12/10/19
12/10
07:39
12/10/19
07:39
Conference/Events
Netflix management to meet with UBS »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

SGEN

Seattle Genetics

$114.26

-3.26 (-2.77%)

07:38
12/10/19
12/10
07:38
12/10/19
07:38
Initiation
Seattle Genetics initiated  »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

SYBT

S.Y. Bancorp

$41.02

-0.03 (-0.07%)

07:38
12/10/19
12/10
07:38
12/10/19
07:38
Conference/Events
S.Y. Bancorp management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DG

Dollar General

$154.81

0.075 (0.05%)

07:37
12/10/19
12/10
07:37
12/10/19
07:37
Hot Stocks
Dollar General announces availability of CBD products in select states »

Dollar General announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HROW

Harrow Health

$6.53

0.04 (0.62%)

07:37
12/10/19
12/10
07:37
12/10/19
07:37
Hot Stocks
Harrow Health subsidiary announces outsourcing facility ships to California »

ImprimisRx, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENB

Tenable Holdings

$24.81

-0.46 (-1.82%)

07:36
12/10/19
12/10
07:36
12/10/19
07:36
Recommendations
Tenable Holdings analyst commentary  »

Tenable Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TROW

T. Rowe Price

$124.48

0.59 (0.48%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Hot Stocks
T. Rowe Price reports preliminary AUM $1.18T at November 30 »

Client transfers from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

FTSV

Forty Seven

$30.44

16.04 (111.39%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Recommendations
Forty Seven analyst commentary  »

Forty Seven price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$47.34

0.62 (1.33%)

, TPR

Tapestry

$25.80

0.26 (1.02%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ZS

Zscaler

$47.34

0.62 (1.33%)

TPR

Tapestry

$25.80

0.26 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 16

    Dec

  • 10

    Jan

FRAN

Francesca's

$19.83

1.29 (6.96%)

07:34
12/10/19
12/10
07:34
12/10/19
07:34
Earnings
Francesca's reports Q3 adj. EPS ($1.12) vs. ($2.08) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

WH

Wyndham Hotels & Resorts

$57.94

-0.1 (-0.17%)

07:34
12/10/19
12/10
07:34
12/10/19
07:34
Conference/Events
Wyndham Hotels & Resorts management to meet with Wolfe Research »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CNST

Constellation Pharmaceuticals

$36.15

-7.95 (-18.03%)

07:33
12/10/19
12/10
07:33
12/10/19
07:33
Recommendations
Constellation Pharmaceuticals analyst commentary  »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

AMGN

Amgen

$232.74

-1 (-0.43%)

07:33
12/10/19
12/10
07:33
12/10/19
07:33
Hot Stocks
Amgen says Phase 3 CANDOR study met primary endpoint »

Amgen announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$17.10

-0.59 (-3.34%)

, BMRN

BioMarin

$78.87

-1.03 (-1.29%)

07:32
12/10/19
12/10
07:32
12/10/19
07:32
Hot Stocks
Invitae launches Discover Dysplasias initiative with BioMarin »

Invitae (NVTA) announced…

NVTA

Invitae

$17.10

-0.59 (-3.34%)

BMRN

BioMarin

$78.87

-1.03 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATI

Allegheny Technologies

$23.76

0.1 (0.42%)

, GE

General Electric

$10.99

-0.105 (-0.95%)

07:32
12/10/19
12/10
07:32
12/10/19
07:32
Hot Stocks
Allegheny Technologies extends long-term purchase agreements with GE Aviation »

Allegheny Technologies…

ATI

Allegheny Technologies

$23.76

0.1 (0.42%)

GE

General Electric

$10.99

-0.105 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

PTON

Peloton

$34.78

2.215 (6.80%)

07:31
12/10/19
12/10
07:31
12/10/19
07:31
Recommendations
Peloton analyst commentary  »

Peloton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVV

Valvoline

$22.21

-0.17 (-0.76%)

07:31
12/10/19
12/10
07:31
12/10/19
07:31
Conference/Events
Valvoline management to meet with Buckingham »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PCG

PG&E

$11.05

1.4 (14.51%)

07:30
12/10/19
12/10
07:30
12/10/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

LEG

Leggett & Platt

$52.17

-0.91 (-1.71%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$93.83

-1.6 (-1.68%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Recommendations
Addus HomeCare analyst commentary  »

Addus HomeCare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.